Gara Jalqabaatti › Obesity › North Carolina › Greensboro
Qorannoo klinikaalii Obesity Greensboro, NC keessatti
Qorannoo 12 Obesity f Greensboro fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Moses H Cone Memorial Hospital, Greensboro
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 2
- Medication Management /ID# 281965, Greensboro
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Medication Management, LLC, Greensboro
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Namoota walitti qabaa jiraSadarkaa 3
- PharmQuest Life Sciences LLC, Greensboro
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Namoota walitti qabaa jiraSadarkaa 3
- Medication Mgmnt, LLC_Grnsboro, Greensboro
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Namoota walitti qabaa jiraSadarkaa 3
- PharmQuest Life Sciences LLC, Greensboro
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Namoota walitti qabaa jiraSadarkaa 3
- Medication Management, Greensboro
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- PharmQuest Life Sciences, LLC, Greensboro
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- Medication Management, Greensboro
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- Medication Management, Greensboro
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Namoota walitti qabaa jiraSadarkaa 3
- PharmQuest, Greensboro
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Kailera Clinical Site, Greensboro
Qorannoo Obesity magaalota biroo keessatti
- Houston, TXQorannoo 43
- Chicago, ILQorannoo 41
- New York City, NYQorannoo 40
- San Antonio, TXQorannoo 40
- Washington, DCQorannoo 33
- Orlando, FLQorannoo 32
- Dallas, TXQorannoo 30
- Boston, MAQorannoo 28
- Las Vegas, NVQorannoo 27
- Miami, FLQorannoo 27
- Baltimore, MDQorannoo 26
- Jacksonville, FLQorannoo 25
Qorannoo biroo Greensboro keessatti
- Baayyee UlfaataaQorannoo 12
- Sukkaraa Gosa 2Qorannoo 6
- Cufama OnneeQorannoo 6
- Saree OljooQorannoo 5
- Dhibee Onneessaa fi DhiigaQorannoo 5
- HIVQorannoo 4
- StrokeQorannoo 4
- Dhukkubbee Onkoloo InterstishiyaliQorannoo 4
- Kutannoo OnneeQorannoo 4
- Dhibee QaraQorannoo 3
- Idiopathic Pulmonary FibrosisQorannoo 3
- AtherosclerosisQorannoo 3
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.